Most hypoglycemia outcomes measured by real-time continuous glucose monitoring can be used to predict future severe hypoglycemia in people with type 1 diabetes, with similar levels of accuracy, study findings indicate.
Researchers have found that, contrary to received wisdom, glycated hemoglobin is an accurate guide to blood glucose levels in patients with cystic fibrosis.
The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.
Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.
Editorial Board member Sanjay Kalra presents his view on the march toward greater integration of digital health technologies and how traditional approaches to diabetes management are already changing.